300463 迈克生物
已收盘 11-15 15:00:00
资讯
新帖
简况
迈克生物（300463）股东郭雷质押670万股，占总股本1.09%
证券之星 · 11-14 21:20
迈克生物（300463）股东郭雷质押670万股，占总股本1.09%
迈克生物最新公告：公司产品取得产品注册证书
证券之星 · 11-14 19:00
迈克生物最新公告：公司产品取得产品注册证书
迈克生物(300463.SZ)取得一项医疗器械注册证
智通财经 · 11-14 18:52
迈克生物(300463.SZ)取得一项医疗器械注册证
迈克生物（300463）11月12日主力资金净买入3460.56万元
证券之星 · 11-13
迈克生物（300463）11月12日主力资金净买入3460.56万元
沃文特IPO行业分类遭监管质疑，张其胜挖老东家“墙角”
市场投研资讯 · 10-29
沃文特IPO行业分类遭监管质疑，张其胜挖老东家“墙角”
迈克生物：10月23日召开分析师会议，包括知名机构正圆投资，高毅资产的多家机构参与
证券之星 · 10-24
迈克生物：10月23日召开分析师会议，包括知名机构正圆投资，高毅资产的多家机构参与
迈克生物转让子公司股权“回血”超2000万元 前三季度净利润止跌回升
每日经济新闻 · 10-24
迈克生物转让子公司股权“回血”超2000万元 前三季度净利润止跌回升
【机构调研记录】蜂巢基金调研天孚通信、迈克生物
证券之星 · 10-24
【机构调研记录】蜂巢基金调研天孚通信、迈克生物
【机构调研记录】红塔红土调研双林股份、迈克生物
证券之星 · 10-24
【机构调研记录】红塔红土调研双林股份、迈克生物
迈克生物（300463）2024年三季报简析：净利润增4.72%，公司应收账款体量较大
证券之星 · 10-24
迈克生物（300463）2024年三季报简析：净利润增4.72%，公司应收账款体量较大
图解迈克生物三季报：第三季度单季净利润同比减15.13%
证券之星 · 10-23
图解迈克生物三季报：第三季度单季净利润同比减15.13%
迈克生物最新公告：拟2394万元转让控股子公司内蒙古迈克全部60%股权
证券之星 · 10-22
迈克生物最新公告：拟2394万元转让控股子公司内蒙古迈克全部60%股权
迈克生物(300463.SZ)拟以2394.01万元出让内蒙古迈克全部60%股权
智通财经 · 10-22
迈克生物(300463.SZ)拟以2394.01万元出让内蒙古迈克全部60%股权
迈克生物(300463.SZ)发布前三季度业绩，净利润2.81亿元，增长4.72%
智通财经 · 10-22
迈克生物(300463.SZ)发布前三季度业绩，净利润2.81亿元，增长4.72%
迈克生物：拟2394.01万元转让内蒙古迈克60%股权
美港电讯 · 10-22
迈克生物：拟2394.01万元转让内蒙古迈克60%股权
迈克生物(300463.SZ)：“胃功能质控品”获产品注册证书
智通财经 · 10-14
迈克生物(300463.SZ)：“胃功能质控品”获产品注册证书
迈克生物(300463.SZ)收到一项医疗器械注册证
智通财经 · 09-20
迈克生物(300463.SZ)收到一项医疗器械注册证
迈克生物最新公告：公司新产品取得产品注册证书
证券之星 · 09-18
迈克生物最新公告：公司新产品取得产品注册证书
迈克生物(300463.SZ)取得一项医疗器械注册证
智通财经 · 09-18
迈克生物(300463.SZ)取得一项医疗器械注册证
迈克生物最新公告：公司及全资子公司新产品取得产品注册证书
证券之星 · 09-04
迈克生物最新公告：公司及全资子公司新产品取得产品注册证书
暂无数据
公司概况
公司名称：
迈克生物股份有限公司
所属行业：
医药制造业
上市日期：
2015-05-28
主营业务：
迈克生物股份有限公司主要从事体外诊断产品研发、生产、销售和服务。公司主营产品包括自产和代理诊断试剂及诊断仪器。公司产品具备国际一流的品质,是国内IVD企业最早建立量值溯源系统的公司，也是国际医学量值溯源体系国际检验医学溯源联合委员会（JCTLM)中首家中国企业代表。
发行价格：
27.96
{"stockData":{"symbol":"300463","market":"SZ","secType":"STK","nameCN":"迈克生物","latestPrice":14.2,"timestamp":1731654231000,"preClose":14.44,"halted":0,"volume":7969048,"delay":0,"floatShares":492000000,"shares":612000000,"eps":0.5312,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.24,"latestTime":"11-15 15:00:00","open":14.44,"high":14.6,"low":14.15,"amount":115000000,"amplitude":0.0312,"askPrice":14.2,"askSize":180,"bidPrice":14.19,"bidSize":92,"shortable":0,"etf":0,"ttmEps":0.5312,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731893400000},"adr":0,"adjPreClose":14.44,"symbolType":"stock","openAndCloseTimeList":[[1731634200000,1731641400000],[1731646800000,1731654000000]],"highLimit":15.88,"lowLimit":13,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":612469590,"pbRate":1.35,"roa":"--","roe":"4.33%","epsLYR":0.5136,"committee":-0.279403,"marketValue":8697000000,"floatMarketCap":6979000000,"peRate":26.731928,"changeRate":-0.0166,"turnoverRate":0.0162,"status":1},"requestUrl":"/m/hq/s/300463/tweets","defaultTab":"tweets","newsList":[{"id":"2483083158","title":"迈克生物（300463）股东郭雷质押670万股，占总股本1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483083158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483083158?lang=zh_cn&edition=full","pubTime":"2024-11-14 21:20","pubTimestamp":1731590429,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物11月14日公开信息显示，股东郭雷向中国银河证券股份有限供公司合计质押670.0万股，占总股本1.09%。质押详情见下表：截止本公告日，股东唐勇已累计质押股份1770.0万股，占其持股总数的26.01%，股东郭雷已累计质押股份2230.8万股，占其持股总数的62.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400036114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0239","300463","BK0046"],"gpt_icon":0},{"id":"2483270768","title":"迈克生物最新公告：公司产品取得产品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2483270768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483270768?lang=zh_cn&edition=full","pubTime":"2024-11-14 19:00","pubTimestamp":1731582037,"startTime":"0","endTime":"0","summary":"迈克生物公告，公司近日收到四川省药品监督管理局颁发的《医疗器械注册证（体外诊断试剂）》，产品为类风湿因子测定试剂盒（胶乳免疫比浊法），主要用于类风湿关节炎的辅助诊断。该产品系公司生化平台第二代试剂盒，在现售产品基础上进行了性能优化，有助于提升用户体验。取得注册证有助于提升公司市场综合竞争力，对市场拓展及未来经营产生积极影响。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400031106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0046","300463","BK0028"],"gpt_icon":0},{"id":"2483275888","title":"迈克生物(300463.SZ)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2483275888","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483275888?lang=zh_cn&edition=full","pubTime":"2024-11-14 18:52","pubTimestamp":1731581575,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)公告，公司近日收到四川省药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》，产品名称为：类风湿因子测定试剂盒(胶乳免疫比浊法)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211056.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300463","BK0012","BK0046","BK1574","09996","BK1222","159883","09997","BK0028","BK1583","BK0239","BK1100"],"gpt_icon":0},{"id":"2483094315","title":"迈克生物（300463）11月12日主力资金净买入3460.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483094315","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483094315?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:17","pubTimestamp":1731460657,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月12日收盘，迈克生物报收于15.12元，上涨2.37%，换手率4.74%，成交量23.29万手，成交额3.54亿元。近5日资金流向一览见下表：迈克生物融资融券信息显示，融资方面，当日融资买入3970.32万元，融资偿还3341.12万元，融资净买入629.19万元。迈克生物主营业务：专注于体外诊断产品的研发、生产、销售和相关服务,坚持以自主研发为主、以客户需求为导向、以满足临床应用为己任,以专业化产品和优质的服务为医学实验室提供整体解决方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300008174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0012","BK0239","300463"],"gpt_icon":0},{"id":"2479413292","title":"沃文特IPO行业分类遭监管质疑，张其胜挖老东家“墙角”","url":"https://stock-news.laohu8.com/highlight/detail?id=2479413292","media":"市场投研资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479413292?lang=zh_cn&edition=full","pubTime":"2024-10-29 10:31","pubTimestamp":1730169060,"startTime":"0","endTime":"0","summary":"截至沃文特递交招股书前，张其胜、杨龙贤、唐前成合计可以控制公司85.13%的股份，为公司共同实际控制人。随着自主业务规模的增长，沃文特的行业分类也遭到了监管质疑。据悉，2021年6月沃文特首次申报报告期内的代理业务收入占比均超过50%，但其将公司行业分类却认定为了“C27 医药制造业”。直至第三轮问询，沃文特依然认定公司的行业分类为“C27 医药制造业”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-10-29/doc-incuetki4735693.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-10-29/doc-incuetki4735693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0046","BK0028","300463","688575","BK0239"],"gpt_icon":0},{"id":"2477527206","title":"迈克生物：10月23日召开分析师会议，包括知名机构正圆投资，高毅资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2477527206","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477527206?lang=zh_cn&edition=full","pubTime":"2024-10-24 14:24","pubTimestamp":1729751082,"startTime":"0","endTime":"0","summary":"全年预算目标为1.4亿元，预计实际收入会更高。心肌炎症等其他板块的测试数增长超过20%，销售收入增长在15%以上。迈克生物2024年三季报显示，公司主营收入19.48亿元，同比下降7.92%；归母净利润2.81亿元，同比上升4.72%；扣非净利润2.92亿元，同比上升6.05%；其中2024年第三季度，公司单季度主营收入6.69亿元，同比下降8.94%；单季度归母净利润7964.66万元，同比下降15.13%；单季度扣非净利润9307.02万元，同比下降3.95%；负债率19.35%，投资收益339.3万元，财务费用1453.3万元，毛利率57.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400018520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463","BK0012","BK0239","BK0046","BK0028"],"gpt_icon":0},{"id":"2477526046","title":"迈克生物转让子公司股权“回血”超2000万元 前三季度净利润止跌回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2477526046","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477526046?lang=zh_cn&edition=full","pubTime":"2024-10-24 12:04","pubTimestamp":1729742640,"startTime":"0","endTime":"0","summary":" 10月22日，迈克生物发布2024年三季度报告，公司前三季度实现营业收入为19.48亿元，同比减少7.92%。归属于上市公司股东的净利润为2.81亿元，同比增长4.72%。 同日，迈克生物公告，拟以2394.01万元的初始交易价格将所持控股子公司内蒙古迈克生物科技有限公司全部60%股权转让给梅仕殿。 10月22日盘后，迈克生物发布转让控股子公司全部股权的公告。此次转让子公司股权“回血”超2000万元，也有望为公司业绩作出一定贡献。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-10-24/doc-inctrpyz6658910.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-10-24/doc-inctrpyz6658910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300463"],"gpt_icon":0},{"id":"2477513344","title":"【机构调研记录】蜂巢基金调研天孚通信、迈克生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2477513344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477513344?lang=zh_cn&edition=full","pubTime":"2024-10-24 08:04","pubTimestamp":1729728280,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为蜂巢恒利债券A，最新单位净值为1.12，近一年增长9.16%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400006971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0214","SGXZ49509284.SGD","BK0086","BK0239","BK0167","BK0012","300394","300463","SGXZ81163826.USD","BK0046"],"gpt_icon":0},{"id":"2477513802","title":"【机构调研记录】红塔红土调研双林股份、迈克生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2477513802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477513802?lang=zh_cn&edition=full","pubTime":"2024-10-24 08:04","pubTimestamp":1729728278,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月23日披露的机构调研信息，红塔红土近期对2家上市公司进行了调研，相关名单如下：1）双林股份 个股亮点：公司新能源汽车领域主要配套车型为华为SF5等。旗下最近一年表现最佳的公募基金产品为红塔红土信息产业精选股票发起式A，最新单位净值为1.22，近一年增长30.76%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400006968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0065","300100","BK0012","BK0014","BK0046","300463","BK0264"],"gpt_icon":0},{"id":"2477599520","title":"迈克生物（300463）2024年三季报简析：净利润增4.72%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2477599520","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477599520?lang=zh_cn&edition=full","pubTime":"2024-10-24 06:06","pubTimestamp":1729721202,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期迈克生物发布2024年三季报。截至本报告期末，公司营业总收入19.48亿元，同比下降7.92%，归母净利润2.81亿元，同比上升4.72%。按单季度数据看，第三季度营业总收入6.69亿元，同比下降8.94%，第三季度归母净利润7964.66万元，同比下降15.13%。本报告期迈克生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达499.77%。去年的净利率为10.52%，算上全部成本后，公司产品或服务的附加值一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400004760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463"],"gpt_icon":0},{"id":"2477363909","title":"图解迈克生物三季报：第三季度单季净利润同比减15.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477363909","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477363909?lang=zh_cn&edition=full","pubTime":"2024-10-23 00:33","pubTimestamp":1729614820,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物2024年三季报显示，公司主营收入19.48亿元，同比下降7.92%；归母净利润2.81亿元，同比上升4.72%；扣非净利润2.92亿元，同比上升6.05%；其中2024年第三季度，公司单季度主营收入6.69亿元，同比下降8.94%；单季度归母净利润7964.66万元，同比下降15.13%；单季度扣非净利润9307.02万元，同比下降3.95%；负债率19.35%，投资收益339.3万元，财务费用1453.3万元，毛利率57.19%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300000212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463"],"gpt_icon":0},{"id":"2477381901","title":"迈克生物最新公告：拟2394万元转让控股子公司内蒙古迈克全部60%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2477381901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477381901?lang=zh_cn&edition=full","pubTime":"2024-10-22 18:39","pubTimestamp":1729593582,"startTime":"0","endTime":"0","summary":"迈克生物公告，为聚焦核心业务、优化资源配置，公司拟以2394.01万元的初始交易价格将所持控股子公司内蒙古迈克全部60%股权转让给梅仕殿。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200030219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0012","BK0239","300463"],"gpt_icon":0},{"id":"2477383199","title":"迈克生物(300463.SZ)拟以2394.01万元出让内蒙古迈克全部60%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2477383199","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477383199?lang=zh_cn&edition=full","pubTime":"2024-10-22 17:43","pubTimestamp":1729590216,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)公告，公司拟以2394.01万元的初始交易价格将所持控股子公司内蒙古迈克生物科技有限公司(简称“内蒙古迈克”)全部60%股权转让给梅仕殿。股权转让完成后，公司不再持有内蒙古迈克股权，不再将内蒙古迈克纳入公司合并报表范围，公司将在内蒙古设立办事处，并通过办事处管理和拓展区域内经销商，持续覆盖和扩大内蒙古区域市场，本次股权转让事项不会对公司主体业务的经营产生重大影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0028","BK0012","BK0239","300463"],"gpt_icon":0},{"id":"2477884753","title":"迈克生物(300463.SZ)发布前三季度业绩，净利润2.81亿元，增长4.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477884753","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477884753?lang=zh_cn&edition=full","pubTime":"2024-10-22 17:32","pubTimestamp":1729589572,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)发布2024年三季度报告，该公司前三季度营业收入为19.48亿元，同比减少7.92%。归属于上市公司股东的净利润为2.81亿元，同比增长4.72%。归属于上市公司股东的扣除非经常性损益的净利润为2.92亿元，同比增长6.05%。基本每股收益为0.4635元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197455.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300463"],"gpt_icon":0},{"id":"2477800286","title":"迈克生物：拟2394.01万元转让内蒙古迈克60%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2477800286","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477800286?lang=zh_cn&edition=full","pubTime":"2024-10-22 17:20","pubTimestamp":1729588842,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","BK0028","BK0046","300463","BK0012"],"gpt_icon":0},{"id":"2475596963","title":"迈克生物(300463.SZ)：“胃功能质控品”获产品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2475596963","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475596963?lang=zh_cn&edition=full","pubTime":"2024-10-14 18:09","pubTimestamp":1728900551,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)公告，公司于近日收到四川省药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》。据悉，胃功能质控品系公司免疫平台新质控产品，主要用于公司胃蛋白酶原I(PG I)、胃蛋白酶原II(PG II)和胃泌素17(G-17)项目的质量控制。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1193549.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300463","BK0012","BK0046","BK0028","BK0239"],"gpt_icon":0},{"id":"2468617108","title":"迈克生物(300463.SZ)收到一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468617108","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468617108?lang=zh_cn&edition=full","pubTime":"2024-09-20 17:33","pubTimestamp":1726824787,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)公告，公司近日收到四川省药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》，产品名称为：促甲状腺激素受体抗体测定试剂盒(直接化学发光法)。促甲状腺激素受体抗体测定试剂盒(直接化学发光法)主要用于毒性弥漫性甲状腺肿的辅助诊断，系公司直接化学发光技术平台试剂新产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","09996","BK0239","159883","BK1100","BK0012","BK1574","09997","BK1222","BK1583","BK0046","300463"],"gpt_icon":0},{"id":"2468972370","title":"迈克生物最新公告：公司新产品取得产品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2468972370","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468972370?lang=zh_cn&edition=full","pubTime":"2024-09-18 16:55","pubTimestamp":1726649708,"startTime":"0","endTime":"0","summary":"迈克生物公告，公司近日收到四川省药品监督管理局颁发的《医疗器械注册证（体外诊断试剂）》，产品为纤溶酶原活性测定试剂盒（发色底物法），主要用于评估纤溶功能状态。该产品的注册证取得进一步丰富了公司产品项目菜单，有助于提升公司市场综合竞争力，对市场的拓展以及公司未来的经营将产生积极影响。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800023839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0046","BK0028","300463","BK0239"],"gpt_icon":0},{"id":"2468725813","title":"迈克生物(300463.SZ)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468725813","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468725813?lang=zh_cn&edition=full","pubTime":"2024-09-18 16:29","pubTimestamp":1726648145,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)公告，公司近日收到四川省药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》，产品名称为：纤溶酶原活性测定试剂盒(发色底物法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184079.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","BK1100","BK1583","09996","BK0239","BK0028","159883","BK0012","09997","BK1574","300463","BK0046"],"gpt_icon":0},{"id":"2464832339","title":"迈克生物最新公告：公司及全资子公司新产品取得产品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2464832339","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464832339?lang=zh_cn&edition=full","pubTime":"2024-09-04 16:47","pubTimestamp":1725439633,"startTime":"0","endTime":"0","summary":"迈克生物公告，公司及其全资子公司迈克电子近日收到国家药品监督管理局颁发的《医疗器械注册证（体外诊断试剂）》。具体产品包括弓形虫IgM抗体检测试剂盒、单纯疱疹病毒2型IgG抗体检测试剂盒、风疹病毒IgM抗体检测试剂盒以及风疹病毒IgG抗体测定试剂盒，这些产品主要用于相关病毒感染的辅助诊断。此外，公司还获得了全自动血型分析仪的注册证。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090400027297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0046","300463","BK0239","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2015-05-28","address":"四川省成都市郫都区高新区百川路16号","stockEarnings":[{"period":"1week","weight":-0.0274},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.119},{"period":"6month","weight":0.0847},{"period":"1year","weight":-0.0617},{"period":"ytd","weight":-0.0448}],"companyName":"迈克生物股份有限公司","boardCode":"AI0027","perCapita":"12982股","boardName":"医药制造业","registeredCapital":"61246万元","compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.0399},{"period":"3month","weight":0.1567},{"period":"6month","weight":0.056},{"period":"1year","weight":0.0917},{"period":"ytd","weight":0.1196}],"survey":" 迈克生物股份有限公司主要从事体外诊断产品研发、生产、销售和服务。公司主营产品包括自产和代理诊断试剂及诊断仪器。公司产品具备国际一流的品质,是国内IVD企业最早建立量值溯源系统的公司，也是国际医学量值溯源体系国际检验医学溯源联合委员会（JCTLM)中首家中国企业代表。","serverTime":1731799395412,"listedPrice":27.96,"stockholders":"37858人(较上一季度增加0.45%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈克生物(300463)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈克生物(300463)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈克生物,300463,迈克生物股票,迈克生物股票老虎,迈克生物股票老虎国际,迈克生物行情,迈克生物股票行情,迈克生物股价,迈克生物股市,迈克生物股票价格,迈克生物股票交易,迈克生物股票购买,迈克生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈克生物(300463)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈克生物(300463)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}